網頁Drug diffusion and biological responses of arteries using a drug-eluting stent with nonuniform coating. Fulltext. Metrics. Get Permission. Cite this article. Authors Saito N, Mori Y, Uchiyama S. Received 8 December 2015. Accepted for publication 20 January 2016. Published 17 March 2016 Volume 2016:9 Pages 33—43. 網頁2011年4月1日 · The polymer-free biolimus A9-eluting stent, with two different doses of biolimus, demonstrated noninferiority compared to PES in the first-in-human BIOFREEDOM study. 39 An in-stent LLL of 0.17 mm …
Restenosis Circulation: Cardiovascular Interventions
A stent is a small mesh tube typically used to hold open passages in the body, such as weak or narrowed arteries. Stents are often used to treat narrowed coronary arteries that provide the heart with oxygen-rich blood. 查看更多內容 Some stents are used in the lung airways. 1. Metal stentsare made of bare metal or covered with another material such as silicone. Hybrid stents contain a … 查看更多內容 Stent grafts are used to treat aortic aneurysms. The stent graft is typically a tube made of leak-proof polyester with a metal mesh backbone. Stent grafts are … 查看更多內容 Some stents are used specifically in the coronary or carotid arteries. 1. Bare metal stents aresimple tubes made of metal mesh that can be used in both the … 查看更多內容 網頁2024年4月12日 · Background and Objectives: Bleeding is one of the most feared and frequent adverse events in the case of EUS-guided drainage of WOPN using lumen-apposing metal stents (LAMSs) and of direct endoscopic necrosectomy (DEN). When it occurs, its management is still controversial. In the last few years, PuraStat, a novel … long single fitted sheets for adjustable beds
Medicina Free Full-Text The Use of PuraStat® in the Management of Walled-Off Pancreatic Necrosis Drained Using Lumen-Apposing Metal Stents…
網頁2024年2月1日 · Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology for the treatment of coronary artery disease. The technology was introduced to … 網頁2024年4月13日 · Zinc is proposed as an exciting new biomaterial for use in bioresorbable cardiovascular stents. It shows sufficient mechanical and biological characteristics required for optimal stent performance. Zinc and its alloys show the appropriate rate of degradation for stent application (0.02 mm/year [ 132, 133 ]). 網頁(New England Journal of Medicine, 334:561-61) demonstrated that stents reduce restenosis: Only 2.1 % of heart attack patients with stents required repeat angiopla ty, whereas 7.7% … hope network corunna rd flint mi